Possible contribution of IGF-1 to depressive disorderAntidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanismEffects of pilocarpine- and kainate-induced seizures on thyrotropin-releasing hormone biosynthesis and receptors in the rat brainEffect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells.Impact of 17beta-estradiol on cytokine-mediated apoptotic effects in primary hippocampal and neocortical cell cultures.Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway.Inhibitory effects of 1,25-dihydroxyvitamin D3 and its low-calcemic analogues on staurosporine-induced apoptosis.Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells.Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons.Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.On some neurochemical aspects of kindling.Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons.Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain.Neurochemical and pharmacological aspects of cocaine-induced seizures.The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein.[The neurochemical mechanisms of temporal lobe epilepsy: an update].[Endocrine effects of antiepileptic drugs].[Effects of antiepileptic drugs on immune system].Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cellsNeuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.The Crucial Involvement of Retinoid X Receptors in DDE Neurotoxicity.The Beneficial Impact of Antidepressant Drugs on Prenatal Stress-Evoked Malfunction of the Insulin-Like Growth Factor-1 (IGF-1) Protein Family in the Olfactory Bulbs of Adult Rats.Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives.New targets for putative neuroprotective agents.Pro-apoptotic Action of Corticosterone in Hippocampal Organotypic Cultures.The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver.Nanocapsules with Polyelectrolyte Shell as a Platform for 1,25-dihydroxyvitamin D3 Neuroprotection: Study in Organotypic Hippocampal Slices.The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression.Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update.Research advances in basic mechanisms of seizures and antiepileptic drug action.New trends in the neurobiology and pharmacology of affective disorders.Neuroendocrine link between stress, depression and diabetes.Crosstalk between contact hypersensitivity reaction and antidepressant drugs.Seizure-induced expression of G proteins in the rat hippocampus.Antiepileptic drugs and adverse skin reactions: An update.The difference in the tail-flick latency between C57BL/6 and DBA/2J mice.The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.
P50
Q27002937-F291EAEB-0F7C-4A58-8131-1DB4A225C731Q28344504-B1F277E3-E567-4555-962D-A724598F8C71Q28370634-4E9069BE-C05B-44F0-A366-5DB36184736FQ33223085-F956E24E-FB0B-49B1-B60F-9E99A6BEA59EQ33256158-EBDC13C3-246C-4E09-800E-585221818922Q33270778-64B789B9-A27D-49AC-A51B-5D3A33BBC838Q33300659-8915F681-F123-4E37-AF3D-324BD230646FQ33314385-28BBC035-B18E-4D14-9776-4CCC3EBF5A46Q33379568-41181D9C-A5F8-421C-AE31-98C06625447AQ33386457-86A8C55C-FD6A-47D1-BEE6-E2F827F33769Q33675892-F4E0CA7B-AF61-431A-AD3D-55192B6F5E46Q33935569-54DF3839-6FAF-4312-AB65-3C4F2FD85C9DQ34085167-C5D64C45-60B8-45B1-A1BF-A1D7DEAA3824Q34405435-A8EB4E62-DFEE-4C1E-A0F8-B0690CECB886Q34418779-E8DF47F8-5035-48E7-A304-7F7828625A0AQ34442872-D8F08286-5213-44D8-99B7-8CA859162253Q34489704-F8657E8A-4B16-49F5-9A57-B5A076F575BBQ34590861-3BAA59B1-2ABA-4974-AB44-68CAE7118CFCQ34769723-D7BB398C-7FD3-43FC-A345-F975FBF3D4B7Q34941052-780351D3-36E9-48BE-BFF1-E2ED9EE12DE2Q34941071-A58D72AA-87C0-4973-99FB-04519689E877Q35170354-44D4E9ED-ADA8-45F1-8BD3-ACA1FC2169E7Q35171790-08DB74F7-E15D-49CA-A6F8-3847A58AD4A8Q35840360-A9AB45EF-AF0F-4C84-948A-4F09C50EC763Q36460423-82BADC7F-A872-4747-BE9E-081036280FA5Q36723475-B6723FF3-7BA2-4B8F-B57B-726B9C84E1FBQ36759299-40E8D44F-29F5-4720-86A1-9A61AB40BCB8Q37099315-4BBEB5F8-DB91-4B9C-9625-5F5A4166A5CEQ37099353-4E15E792-0B25-4DD3-9BFE-83ABFA851AA4Q37306528-F96D8D45-F400-416E-BA09-AD44205A84BFQ37408016-5C538441-218B-42F0-A9A7-6C876A2B011FQ37878206-FB3D8D99-6C8A-47FF-A96E-32FEFE1E67E4Q38154412-5ACD0515-CAA6-4D3E-9AC5-D0B976D296AEQ38189542-13D0F781-5214-47E8-85D1-F38EBC1AB7B2Q38189558-3EF8A09B-D33F-473B-8635-BF30640E6F22Q38189566-17B480DE-1B39-4B86-85DE-AB57E74FF486Q38306760-DCFC9356-0837-4721-8FC6-B75D3D21556BQ38453964-7469959D-34B3-4FBB-9678-AC54F8D89ADBQ38518561-295B7AEA-3F76-4F8B-A6AF-47E1841F836FQ38710632-F21666CA-C8A9-4522-A9C2-6CEC515AA630
P50
description
Polish neuropharmacologist
@en
Pools farmacoloog
@nl
polski lekarz, neurofarmakolog
@pl
name
W Lason
@ast
W Lason
@es
W Lason
@nl
Władysław Lasoń
@ca
Władysław Lasoń
@cs
Władysław Lasoń
@en
Władysław Lasoń
@gl
Władysław Lasoń
@hr
Władysław Lasoń
@hsb
Władysław Lasoń
@it
type
label
W Lason
@ast
W Lason
@es
W Lason
@nl
Władysław Lasoń
@ca
Władysław Lasoń
@cs
Władysław Lasoń
@en
Władysław Lasoń
@gl
Władysław Lasoń
@hr
Władysław Lasoń
@hsb
Władysław Lasoń
@it
altLabel
W Lason
@en
Wladyslaw Lason
@en
Władysław Lasoń (farmakolog)
@pl
prefLabel
W Lason
@ast
W Lason
@es
W Lason
@nl
Władysław Lasoń
@ca
Władysław Lasoń
@cs
Władysław Lasoń
@en
Władysław Lasoń
@gl
Władysław Lasoń
@hr
Władysław Lasoń
@hsb
Władysław Lasoń
@it
P214
P106
P1153
7006226163
P1412
P1559
Władysław Lasoń
@pl
P21
P214
P27
P31
P3124
P496
0000-0001-9640-2159
P735
P7859
viaf-166367728